Clinical Trials on ICU-acquired Weakness
Total 0 results
Nothing found
Sponsors and Collaborators
- Faculdade de Medicina da Universidade do Porto (FMUP)
- The First Affiliated Hospital of Air Force Medicial University
- Delosis Limited
- Prof. Jürgen Kuschyk, M.D
- Jikei University School of Medicine
- InfraScan, Inc.
- RINO ZUID
- University of Natural Resources and Life Sciences, Vienna, Austria
- Institute of Antibiotics, Huashan Hospital, Fudan University
- Jiajie Chen
- Deutsche Arthrose-Hilfe
- Stefania Basili
- Shamir Optical Industry Ltd
- Research Unit of General Practice, Odense
- Donna Hammond, PhD
- IDRI Corporation
- Centre Hospitalier de Bastia
- Cooperative Clinical Drug Research and Development AG (CCDRD AG)
- Alfred Hospital Intensive Care Unit Australia
- Canadian Hemophilia Society
- View Full List
Medical Conditions
- Refractory Transformed B-Cell Non-Hodgkin Lymphoma
- Surgery Induced Tissue Adhesions
- Insulin-Dependent Diabetes Mellitus
- Acute Myocardial Infarction, of Inferolateral Wall
- Robot-assisted Laparoscopic Prostatectomy Under General Anesthesia
- Community-Acquired Staphylococcus Aureus
- Incompetence, Functional
- Subgluteal Sciatic Block
- Reduction, Weight
- Neovascular Age-related Macular Degeneration(nAMD)
- Ovarian Aging
- HIV Related Insulin Resistance
- Autosomal Dominant Hypocalcaemia
- UP in Online Group Format
- Asian Consortium
- Sensory Reconstruction of Digits
- Oxidative Stress in Patient With Haemoglobinopathy and Affect it of Endocrine System
- Sepsis and Coagulopathy
- Open Reduction and Internal Fixation
- Colonic Adenoma
- View Full List
Drug Interventions
- Sorafenib and OSI-906
- Epoetin beta (NeoRecormon®)
- Radioligand (11C)AZD2184
- Atorvastatin, 10mg, 20mg, 40mg
- Domperidone
- Rosuvastatin calcium tablets
- Gemcitabine (mg/m²)
- PF regimen (cis-platinum ; 5-fluorouracil ) combined with PD-1 inhibitors（pembrolizumab）
- HLX23
- Prucalopride
- Propranolol Hydrochloride Extended Release Capsules 160 mg
- Moxifloxacin
- LIS 18 U
- Nanoliposomal Irinotecan
- JR-141
- Chlorcyclizine HCl
- Arm 1 - GEH120714 (18F) Injection
- Hypertonic saline
- INCB7839
- 13 valent pneumococcal conjugate vaccine and 23 valent pneumococcal polysaccharide vaccine
- View Full List
CROs by country
- Contract Research Organizations in Armenia
- Contract Research Organizations in Austria
- Contract Research Organizations in Denmark
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Mexico
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Oman
- Contract Research Organizations in South Africa
- Contract Research Organizations in Togo
- Contract Research Organizations in United Kingdom
- Contract Research Organizations in Zimbabwe
- CRO list by country